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Introduction
Later childbearing has become a widespread phenom-
enon in the developed countries in the last three decades [1]. 
In our country the proportion of 35-year-old women and 
older ones in prenatal medical and obstetrical service insti-
tutions has also increased signifi cantly in the recent years. 
By the evidence of the National Center of Statistics during 
the last decade the rate of birth for women over 35 years old 
increased from 5.7% in 2000 to 7.2% in 2011 [2].
Th e medical risks of the pregnancy for women over 35 
years old are related to the ageing of body and reproductive 
system that includes an increasing risk of a fetal loss, such 
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Abstract
Pregnancy induced hypertension, which includes both gestational hypertension (GH) and preeclampsia, is the most common medical disorder and 
remains one of the major causes of maternal and fetal death. The pathogenesis of GH is still unknown, yet immunologic and inflammatory causes may 
play an important role in the pathophysiology of this disease. The purpose of this study is to investigate the midtrimester IL-6, IL-8, IL-10, IL-12, TNF-α, 
SDF-1a and VEGF in the amniotic fluid (AF) and maternal blood regarding the above as being predictive for the gestational hypertension outcome. In 
the group of 128 pregnant women over 35 years old the six ones have developed GH. Our study results demonstrate that GH is associated with a strong 
increase of IL-6, IL-12 in maternal blood and a significant decrease of serum IL-10. Although AF level of both IL-6 and IL-10 has been significantly 
lower in GH subjects. In conclusion this study shows the relationship between the midtrimester IL-6, IL-12 and IL-10 concentrations in AF and maternal 
serum and GH outcome.
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Реферат
Артериальная гипертензия при беременности, включающая в себя гестационную гипертензию и преэклампсию, является наиболее частым 
из осложнений беременности и остаётся одной из основных причин материнской смертности и гибели плода. Патогенез гестационной гипер-
тензии до сих пор полностью не изучен, однако иммунологические и воспалительные факторы могут играть важную роль в патофизиологии 
этого заболевания. Целью данного исследования является изучение в период второго триместра беременности соотношения концентраций 
IL-6, IL-8, IL-10, IL-12, TNF-α, SDF-1a и VEGF в амниотической жидкости плода и материнской сыворотке крови и их связь с последующим 
развитием гестационной гипертензии. В группе из 128 беременных в возрасте старше 35 лет, в шести случаях выявлено развитие гестационной 
гипертензии. Полученные результаты определили, что наличие гестационной гипертензии связано с существенным увеличением концентрации 
сывороточного IL-6 и IL-12 и одновременным снижением IL-10 в крови матери, при том, что в амниотической жидкости выявлено существен-
ное снижение как IL-10, так и IL-6. В заключении данное исследование доказывает связь между уровнями IL-6, IL-10 и IL-12 в амниотической 
жидкости плода и крови матери, выявленными во втором триместре беременности, и последующим развитием гестационной гипертензии.
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chromosome anomalies as a Down syndrome, a multiple 
pregnancy, diabetes, a placenta previa, a placental abruption, 
Caesarean birth, a preterm labour and a low birth weight, but 
the leading causes of maternal and neonatal morbidity and 
mortality worldwide still remains preeclampsia, which may 
occur due to the pregnancy induced hypertension (PIH) [3, 
4, 5]. High blood pressure during the pregnancy increases 
the resistance of blood vessels, which can hinder blood fl ow 
in diff erent organ systems including the uterus, liver, kid-
neys, brain and placenta. Th at is why a placental abruption 
sometimes may occur as a result of gestational hypertension 
what can lead to the fetal problems including an intrauterine 
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growth restriction and a stillbirth. In this case the preceding 
diagnosis of GH is of major importance to prevent the pos-
sible complications during the labour. Th e early detection 
of pregnancy complications such as GH and preeclampsia 
would allow the maximum time for initiation of treatment 
and might help prevent some complications of the disease. 
In practice, the clinical symptoms of the disease oft en appear 
too late to allow a worthwhile intervention. Commonly used 
tests, those that reveal the increase of C-reactive protein, leu-
kocyte subsets and concentrations of pro-calcitonin are non-
specifi c and, certainly, unreliable for a true identifi cation.
Many studies have investigated the role of cytokines in 
the pathogenesis of the essential hypertension. Th e experi-
mental evidence shows that the rennin angiotensin system 
(RAS) and the sympathetic nervous system interact with 
such pro-infl ammatory cytokines as IL-6 and TNF-α and 
stimulate chemokine monocyte chemoattractant protein-1 
and nuclear factor-κB. Simultaneously, pro-infl ammatory 
cytokines increase the production of reactive oxygen species; 
they also aff ect a vascular function and endothelium-derived 
factors involved in blood pressure regulation [6, 7, 8, 9]. Sev-
eral investigations with the usage of amniotic fl uid samples 
suggest the role of pro-infl ammatory cytokines as biomark-
ers for pathological gestations and, especially, for intrauter-
ine infection, but the fi ndings concerning a predictive role of 
cytokines for PIH and preeclampsia relating to the age of the 
mother remain inconclusive [10, 11].
In the Republic of Moldova, according to the Guidelines 
for Perinatology, pregnant women aft er 35 years old belong 
to the risk group and require an additional monitoring, 
which includes specifi c tests for detecting congenital malfor-
mations [12]. Th e cultivation of amniotic fl uid is still consid-
ered a gold standard for the identifi cation of certain kinds of 
birth defects and is done between the 15th and 20th weeks of 
pregnancy [13].
Th e aim of this study is to fi nd a correlation between the 
pregnancy with GH outcome and concentrations of immune 
mediators IL-6, IL-8, IL-10, IL-12, TNF-a, VEGF and SDF-
1a in fetal amniotic fl uid and maternal blood collected dur-
ing the second trimester of pregnancy from women aft er 35 
years old.
Material and methods
Subjects
A clinical trial has been performed in the National Center 
of Reproductive Health and Genetics in the Republic of Mol-
dova and has included the pregnant women aft er 35 years old, 
who have been subjected to an invasive prenatal diagnostics 
during the years of 2011 and 2012. According to the preg-
nancy outcome, from a cohort of 128 women 6 patients have 
been included in the group with GH and 17 women with 
uncomplicated normal pregnancies have been included in a 
comparison group. All the subjects have been normotensive 
before 20 weeks’ gestation and in all the cases the hypertensi-
on has been lowered in the postpartum period.
Th e maternal age has ranged from 35 to 40 years old 
(36.8 ± 0.59) in the control group and from 35 to 38 years 
old (36.2 ± 0.54) in the hypertensive group. Th e mean arte-
rial pressure (MAP) has been calculated as diastolic pressure 
plus one third of the pulse pressure.
Th e study has been approved by the Medical Ethics Com-
mittee, State University of Medecine and Pharmacy “Nicolae 
Testemitsanu”. An informed consent has been obtained from 
each subject at the beginning of the study. 
Amniocentesis and blood samp les
Th e intervention has been performed transabdomenally 
aseptically under the ultrasound guidance, 20 ml of amniotic 
fl uid has been extracted fi rst for the further diagnostic tests 
according to the cytogenetical screening, subsequently 10 ml 
of amniotic fl uid has been removed and divided into 2 ml 
aliquots and stored at -48°C until being analyzed.
The venous blood has been collected aft er the amnio-
centesis procedure and drawn into the specimen tubes for 
serum extractions and tubes containing EDTA as anticoa-
gulant for plasma extractions. Th e plasma and serum have 
been prepared by centrifugation, aliquoted and stored at 
-48° C until being analyzed.
Assay of serum and amniotic fl uid cytokines concen-
trations
Th e IL-6, IL-8, IL-10, IL-12, TNF-α, VEGF and SDF-1a 
concentrations have been measured by specifi c quantitative-
ly aff ordable enzyme linked immunosorbent assay (ELISA) 
kits (PeproTech Inc., Minneapolis, USA.) according to the 
manufacturer’s instructions. Th e assays have been carried 
out in fl at-bottomed 96-well immunoplates (MaxiSorp, 
Nunc, Wiesbaden, Germany). Th e amniotic fl uid and serum 
have been measured using BioTek’s PowerWave HT micro-
plate spectrophotometer. A standard curve has been made 
in parallel to each assay and the results have been converted 
into pg/mL.
Statistical analysis
Th e statistical analysis of the data has been performed by 
two-tailed Student's t-test and ANOVA test. Th e diff erences 
have been considered signifi cant for p ≤ 0.05 and highly sig-
nifi cant for p ≤ 0.01. Th e data are presented as a mean value 
± SEM.
Results
In a cohort of 128 pregnant women over 35 years old ex-
amined in the present study, the six ones have developed the 
gestational hypertension. In all the cases the hypertension 
has occurred aft er 32 weeks of gestation and has not been 
complicated by proteinuria.
Th ere have not been diff erences between the two study 
groups regarding MAP baseline values before the time of 
20 weeks of gestation (88.5 ± 2.05 mm Hg in GH group 
vs. 89.4 ± 1.59 mm Hg in control group; p = 0.72). On the 
other hand, at the 32-35th weeks of gestation a statistically 
signifi cant increase of MAP (p < 0.001) has been noted in 
GH group (111.1 ± 0.82 mm Hg) while there have not been 
considerable changes in the control subjects (90.0 ± 1.51 mm 
Hg) (fi g. 1).
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Fig. 1. The mean arterial pressure (MAP) during pregnancy.
All the data are expressed as a mean value ± SEM. *** p < 0.001.
IL-6, IL-8, IL-10, IL-12, TNF-α, SDF-1a and VEGF have 
all been found in the AF and mothers’ blood in the second 
trimester of pregnancy.
Th e signifi cant positive correlation has been between 
pro-infl ammatory IL-6 in the blood collected from the preg-
nant women who have developed the GH (p < 0.05) and the 
control group. On the other side, in the AF the concentra-
tions of IL-6 have showed an opposite trend. Th ere the levels 
of IL-6 in AF from GH group have been signifi cantly lower 
(p < 0.05) in comparison to the normal pregnancy group.
Th e concentrations of anti-infl ammatory IL-10 also show 
a positive correlation between GH and the development of 
pregnancy. Th e blood levels of IL-10 in the GH group have 
been signifi cantly lower (p = 0.017) than in the control 
group. Similarly, there has been a signifi cant decrease of IL-
10 in the AF collected from the subjects with GH (p < 0.01).
Th e serum levels of IL-12 in the pregnancy complicated 
by GH have been elevated approximately twice as much in 
comparison with the control group, however there has been 
no statistical diff erence between these groups (p = 0.06). One 
woman from uncomplicated pregnancy group has displayed 
a clearly diff erent from the rest of this group (223-1585 pg/
ml) IL-10 level (2098 pg/ml) and by excluding it from the 
calculations a statistically signifi cant diff erence between the 
groups (p = 0.04) has been obtained. Nonetheless, there has 
been no diff erence between IL-12 levels in the AF in the both 
groups, and the average value has been approximately equal.
TNF-α has been detected in the maternal serum only in 
a few samples taken from the both investigated groups (the 
data is not shown). In the AF samples the TNF-α concentra-
tions have been low and approximately similar varied in the 
both groups (p = 0.247).
Th e concentrations of other investigated cytokines – IL-
8, VEGF and SDF-1a – have not been diff erent both in the 
maternal blood and the AF in the GH group subjects and 
control ones (tab. 1).
Discussion
Th e pathogenesis of GH is still unknown, yet immuno-
logic and infl ammatory factors may play an important role 
in the pathophysiology of this disease. IL-6 and other pro-
infl ammatory cytokines are the important components of 
immune response and according to our fi ndings appear to 
be involved in the early cellular disorders that underlie GH. 
Th e measurement of immune mediators in the period of 
pregnancy has been the method to diagnose an intrauterine 
infection; in our case we have considered that this measure-
ment can be correlated with the early identifi cation of GH.
Our results demonstrate that GH is associated with the 
signifi cant increase of IL-6 in blood in the second trimes-
ter of pregnancy when the blood pressure is unchanged. 
Th is fi nding is consistent with some previous reports by 
Munno et al. [14], Teran et al. [15], Afshari et al. [16], who 
have found the increase of serum IL-6 in women with pre-
eclampsia and suggested a potential role of this infl amma-
tory cytokine in the etiology of preeclampsia. In our study 
nobody have had proteinuria which is the main component 
for the pathogenesis of preeclampsia. It is already well de-
Table 1
Concentrations of IL-6, IL-8, IL-10, IL-12, TNF-α, SDF-1α and VEGF measured in the second trimester 
maternal blood and amniotic fluid samples obtainied from the unaffected women and women who developed 
gestational hypertension later
Immune me-
diators
The average pg/mL concentration range
In amniotic fluid p In maternal serum p
GH (n = 6) Control (n = 17) GH (n = 6) Control (n = 17)
IL-6 1701.67 ± 199.6 2378.22 ± 235.66 0.042 1957.00 ± 314.17 1055.18 ± 81.14 0.034
IL-8 2886.33 ± 471.76 2718.71 ± 315.35 0.77 371.17 ± 55.06 332.35 ± 25.06 0.54
IL-10 934.00 ± 97.48 1776.71 ± 253.31 0.006 260.00 ± 11.16 430.82 ± 63.51 0.017
IL-12 1850.00 ± 195.29 1898.00 ± 115.46 0.837 1414.17 ± 290.58 709.82 ± 126.73 0.062
SDF-1α 1473.67 ± 111.71 1442.71 ± 72.59 0.821 629.83 ± 101.01 522.76 ± 43.66 0.363
VEGF 2342.33 ± 109.26 2107.65 ± 492.98 0.648 404.33 ± 44.22 356.58 ± 40.98 0.442
TNF-α 55.81 ± 28.48 18.14 ± 1.63 0.247 - - -
All data are expressed as a mean value ± SEM.
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fi ned that IL-6 can increase the permeability of endothelial 
cells, reduce the prostacyclin synthesis by inhibiting the cy-
clooxygenase enzyme, increase the tromboxane A2 to pros-
tacyclin ratio and also stimulate a platelet-derived growth 
factor [16]. Also, IL-6 can stimulate the expression of RAS 
components and leads to the increase of angiotensin II level 
which has a dominant role in the pathogenesis of hyperten-
sion [8, 9]. At the same time it has been demonstrated that 
angiotensin II stimulates the release of IL-6, and angiotensin 
type I receptor antagonist lowers aortic mRNA expression of 
pro-infl ammatory cytokines IL-1β, TNF-α and IL-6 as well 
as plasma levels of IL-6 and IL-1β. Also, the eff ects of IL-6 
on vascular contractile mechanisms have been shown, the 
fact that supports the hypothesis that IL-6 can play its role in 
the hypertensive actions of angiotensin II [17, 18, 19]. Fur-
thermore, IL-6 can induce secreting of auto antibodies that 
activate angiotensin II type I receptor (AT1-AA) [20], w hat 
supports the hypothesis that IL-6 can play an important role 
in the development of PIH.
Our results on IL-6 in the AF are consistent with those 
from the previous studies that show the relationship be-
tween PIH and the concentrations of IL-6. Silver et al. [21] 
has found that the low levels of IL-6 correlate with small-for-
gestational-age fetuses and preeclampsia, whereas its elevated 
levels correlate with preterm labour and delivery. Diff erent 
observations show the elevated mildtrimester levels of IL-6 in 
the AF in the pregnancies with subsequent preeclampsia, but 
it is not clear if there has been any maternal infection; yet the 
maternal infection is a potent stimulus for IL-6 production.
IL-10 is a particularly intriguing cytokine as it is char-
acterized as pleiotropic and having a dual immunologic 
function. Th e previous studies have evaluated the concen-
trations of circulating IL-10 in pregnant women with PIH 
and preeclampsia; however, the results remain controversial 
[22, 23]. Our fi nding of a signifi cant decrease of IL-10 in the 
AF and maternal serum in the GH group compared with the 
control group suggests that this cytokine is involved in the 
pathogenesis of GH. It is suggested that IL-10 has a protec-
tive eff ect on the fetal-placental unit because it inhibits the 
secretion of such infl ammatory cytokines as IL-6 and TNFα 
[23]. According to the above authors, IL-10 reconstitution 
prevents the onset of preeclampsia-associated features in 
both in vivo and in vitro models of preeclampsia.
We have observed a strong tendency towards the higher 
levels of IL-12 in the blood of the GH group subjects com-
pared with the unaff ected pregnancy subjects. Our results 
comply with the similar fi ndings that have found that serum 
IL-12 concentrations are elevated in women with both se-
vere preeclampsia and HELLP syndrome. Th e authors in the 
modern literature suggest that the regulation of the IL-12 
production and metabolism are abnormal in women with 
preeclampsia and HELLP syndrome what, perhaps, contrib-
utes to the immunologic alterations characteristic of these 
disorders [24].
In conclusion the research group demonstrates the re-
lationship between the midtrimester IL-6, IL-12 and IL-10 
concentrations in the AF and maternal serum and GH out-
come. We report the dependence between the elevated ma-
ternal level of IL-6 and IL-12 and the decreasing concentra-
tion of IL-10 and the subsequent development of GH, mostly 
aft er 32 weeks of gestation. We also provide the evidence of 
the association between the decreased levels of IL-6, IL-10 in 
the AF and GH in women aged over 35. Further studies are 
required to produce more consistent results that can benefi t 
the fi eld of obstetrics.
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